Sarah Jane Jacobsen (CTA)’s Post

SitePlus – developed in partnership with THREAD – has been enhanced to offer advanced central site services and technology features for both interventional and post-approval research studies. This joint offering provides a proven, next-generation research model that can be initiated from initial study design and launch or added alongside any ongoing Phase II – IV study. Learn more about how SitePlus can help you by bring the promise of hybrid study designs to life through expanding access to addressable patient populations, accelerating enrollment, and improving patient retention. Discover how SitePlus is keeping patients engaged and transforming how studies are designed, and data is captured https://hubs.li/Q02BPm-r0 #PatientsFirst #SitePlus #Pharma #ClinicalTrials #CRO

🚀✨ Excited to share what OUR TEAM at AK Clinical Research is doing! We are a boutique CRO dedicated to offering our 👐 'Helping Hand' 👐 🔍 Our tailored monitoring solutions prioritize quality, efficiency, and most importantly, the success of clinical trials 🧬. Whether you're; 1.) launching a new study 📈, 2.) seeking to enhance your clinical trial 💡, 3.) need a clinical trial health check 🩺, 4.) or even require a full rescue on an ongoing project 🚑, AK Clinical Research’s team is here to elevate your clinical research experience 🏆🌟 #ClinicalTrials #ClinicalResearch #CRO #HealthcareInnovation #ClinicalMonitoring #ResearchExcellence #Biotech #Pharma #LifeSciences #MedicalResearch #DrugDevelopment #HealthTech #Innovation #Science #Biotechnology #ClinicalDevelopment #ClinicalOperations #ResearchAndDevelopment #MedTech #Healthcare #ClinicalData #ClinicalSolutions #PatientSafety #TherapeuticInnovation #TrialManagement

Join Janice Chang, CEO of TransCelerate BioPharma Inc. and Dr. Mark McClellan, Director of Duke-Margolis Institute for Health Policy and Former Commissioner, FDA at #SCOPEsummit in February in Orlando to hear their special keynote co-presentation: Fast Forward to 2035: What Success Could Look Like in Converging Clinical Research and Care—And How to Get There On the #SCOPEsummit stage in 2024, TransCelerate, #Pharma, and #Biotech leaders spoke about the mission to converge clinical research and clinical care for the benefit of patients worldwide. The goal is to create a world where patients participate in research at the point of care as seamlessly as possible. The real fruits of those efforts will not be seen in the short term. We will use this session to talk about where we hope we will be by 2035. What might we reasonably achieve? What does success look like? And what will it take to get there? This session is designed to help us all to raise our gaze beyond the near-term and find inspiration in the future possibilities. Join 4,500 of your fellow clinical trial execs Feb. 3-6, 2025 in Orlando at SCOPE: https://lnkd.in/gHFBqCh2 #clinicalresearch #clinicaltrials #patientcentricity #CRAACO Heidi (Kestenbaum) White, Allison Cuff Shimooka, Erik Yorke, Deborah Borfitz, Allison Proffitt, Moe Alsumidaie, Lori Ellis, Andy Studna, Cambridge Healthtech Institute

TRIAL NEWS 📣: The Partnership for Advancing Clinical Trials (PACT) consortium, in conjunction with the Tufts Center for the Study of Drug Development, has produced compelling results from a new study on the effectiveness of decentralized clinical trials (DCTs)🔬. In total, 13 clinical trial sponsors & CROs provided robust data on 60 clinical trials that deployed decentralized solutions. The analysis found that actual timelines beat planned timelines from first site activated to first patient enrolled, & from first patient to last patient enrolled ⏩. Early results of the PACT research also suggest that trials with DCT elements have more diverse study volunteers than those without, including a lower percentage of white participants, and higher percentage of Asian participants. Read more here: https://lnkd.in/eevNTkMW ________ Michelle Longmire, Pamela Tenaerts, MD, MBA, Tim Smith, Alison Holland, Jason Rothbart #clinicaltrials #clinicalresearch #healthcare #digitalhealth

GETTING BIOTECHS GLOBALREADY 🌏 GlobalReady is designed to support biotechs from their early pre-clinical through to later phases. All with the one CRO, across the globe, and leveraging the right site relationships and delivering access to patient populations. 🌐 Watch the video 👇 https://lnkd.in/gTtrcAjS Request a Proposal now! https://lnkd.in/gDgtaSqB #AvanceClinical #CRO #GlobalReadybyAvanceClinical #Biotech #ClinicalTrials #DrugDevelopment #PreClinical #EarlyPhase #LatePhase

Our clinical research journey. The key to a clinical trial's success is making patients feel they are being treated as individuals rather than as patients. Contact Synergen Bio today to begin working with us. #Clinicaltrial  #ClinicalResearch #Innovation #Discovery #Bioequivalence #Pharmacokinetics  #RegulatoryCompliance #SynergenBio

When woven into early clinical trial planning, a defined diversity plan can help sponsors to identify, enroll, and retain clinically relevant patients from historically underrepresented populations, without adding substantial time or costs to drug development. Read more in this blog post from IQVIA Biotech’s Erin Finot, MS, MBA and James Kyle Bryan. https://bit.ly/3Vwecng #clinicaltrials #diversity #drugdevelopment

Unlocking the future of healthcare starts with exploration and discovery. 🌍 Medical research and clinical trials pave the way to new treatments that tackle complex diseases. Each trial adds vital knowledge, bringing us closer to life-changing breakthroughs. By participating, you're playing a key role in shaping the future of medicine and making a difference for yourself and others. 🌟 🩺 Medcare Pharma: Your Way to Cure Contact us: ☎️ | 1-866-4-MEDICINE 📧 | info@medcarepharma.care 🌐 | https://lnkd.in/gA9pPUVR #InnovateForHealth #BeTheChange #clinicaltrial #clinicalresearch #medicalresearch #clinicalstudies #clinicalstudy #healthcare #medcarepharma #researchstudies

👉 Clinical Trial Design Innovation Outsourcing-Pharma interviewed Samuel Salvaggio, PhD about how One2Treat is revolutionizing clinical trial designs with a patient-centric approach that dramatically reduces trial sample sizes. In the ever-evolving landscape of clinical research, One2Treat is paving the way for more efficient trials by incorporating patient-relevant outcomes into their primary endpoints. This innovative approach not only accelerates the development of new therapies but also ensures higher precision and more clinically relevant results for patients. 💡 Key Highlights of the Interview: - Involving patients from the design phase ensures a holistic assessment of efficacy, safety, and quality of life. - Leveraging more data (i.e. for each single patient) increases clinical relevance and reduces sample sizes. - Regulatory authorities are promoting innovative methodologies that leverage patient-reported outcomes in their guidance. Discover how One2Treat is driving advancements in clinical trial design. 👉 Read the full article here: https://lnkd.in/dBP4w-FZ #ClinicalTrials #DigitalInnovation #PatientCentric #ReducedSampleSize #RegulatoryCompliance

In the BEAMER project, we are partnering with Takeda, Pfizer, Uniklinik Köln, Tilburg University, Centre for Research & Technology Hellas (CERTH), FIB HNJS, empirica Communication and Technology Research and many other organizations to find an innovative way to improve adherence to treatment in both clinical research and clinical care through optimized and personalized patient support. But we do a lot more than this! Want to know how our Patient Feasibility Services can help you to achieve optimal patient experience and better efficacy and efficiency for your clinical trials? Contact Alexandra Sheren (Americas), Simon Klaasen (Europe &ROW), or Ola Hasselgren (Nordics) to learn more and discuss your specific situation and requirements. Let us know what you think and 𝗳𝗼𝗹𝗹𝗼𝘄 𝘂𝘀. #patientadherence #patientengagement #patientrecruitment #clinicaltrials #clinicaloperations #healthcareinnovations #healthcareprofessionals #patientoutcomes #patientcentricity #clinicalcare #patientexperience #healthjourney #patientjourney #patientparticipation #regulators #valuebasedpricing #valuebasedhealthcare #patientsupport